Unknown primary head and neck squamous cell carcinoma: Molecular identification of the site of origin

Journal of the National Cancer Institute

Volumn 91, Issue 7, 1999, Pages 599-604

  Califano, Joseph ^a   Westra, William H ^a   Koch, Wayne ^a   Meininger, Glenn ^a   Reed, Andre ^a   Yip, Lin ^a   Boyle, Jay O ^b   Lonardo, F ^b   Sidransky, David ^a,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC VALUE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0033531735     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.7.599     Document Type: Article

References (25)

1. de Braud F, al-Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol 1993; 20:273-8.
2. Lee DJ, Rostock RA, Harris A, Kashima H, Johns M. Clinical evaluation of patients with metastatic squamous carcinoma of the neck with occult primary tumor. South Med J 1986;79:979-83.
3. Fried MP, Diehl WH Jr, Brownson RJ, Sessions DG, Ogura JH. Cervical metastasis from an unknown primary. Ann Otol Rhinol Laryngol 1975;84: 152-7.
4. Comess MA, Beahrs OH, Dockerty MB. Cervical metastasis from occult carcinoma. Surg Gynecol Obstet 1957;104:607-17.
5. Davidson BJ, Spiro RH, Patel S, Patel K, Shah JP. Cervical metastases of occult origin: the impact of combined modality therapy. Am J Surg 1994; 168:395-9.
6. Wang RC, Goepfert H, Barber AE, Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990;116:1388-93.
7. Glynne-Jones RG, Anand AK, Young TE, Berry RJ. Metastatic carcinoma in the cervical lymph nodes from an occult primary: a conservative approach to the role of radiotherapy. Int J Radiat Oncol Biol Phys 1990;18:289-94.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
9. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996;56:2488-92.
10. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D. Multiple head and neck tumors: evidence for clonal origin. Cancer Res 1996;56:2484-7.
11. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
12. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-6.
13. Nawroz H, van der Riet P, Hruban RH, Koch W, Ruppert JM, Sidransky D. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994; 54:1152-5.
14. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996;56:3630-3.
15. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, Batsakis JG. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 1994;74: 152-8.
16. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, Myers EN, et al. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chomosomes Cancer 1995;12:288-95.
17. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1994;53:4477-80.
18. Wu CL, Sloane P, Read AP, Harris R, Thakker N. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res 1994;54:6484-8.
19. Maestro R, Gasparotto D, Vuksavljevic T, Barzan L, Sulfaro S, Biocchi M. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993;53:5775-9.
20. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994;54:4603-6.
21. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markowitz S, Willson JK, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50: 7717-22.
22. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997;89:857-62.
23. van der Riet P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54:1156-8.
24. Boyle JO, Mao L, Brennan JA, Koch WH, Eisele DW, Saunders JR, et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994;168:429-32.
25. Mao L, Lee DJ, Tockman MS, Erozan Y, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci U S A 1994;91:9871-5.